摘要
目的:探讨食管鳞癌组织中E-cadherin蛋白表达对术后预后的影响。方法:5 620例1985年至2016年间收集的食管鳞癌患者生物样本及临床病理信息均来自河南省食管癌重点开放实验室建立的50万例食管癌和贲门癌临床信息数据库,利用组织芯片和SP免疫组化法测定患者食管鳞癌组织中E-cadherin的表达。结果:男性患者中,分化程度低、淋巴结转移阳性、病理分期晚的患者E-cadherin表达强于分化程度高、淋巴结转移阴性、病理分期早者(P <0. 05)。女性患者中,淋巴结转移阳性、病理分期晚的患者E-cadherin表达强于淋巴结转移阴性、病理分期早者(P <0. 05)。Cox回归分析结果显示,E-cadherin阳性表达不是女性患者术后预后的独立影响因素(P=0. 089);但是男性患者的术后预后独立危险因素,HR(95%CI)为1. 126(1. 066~1. 189)。结论:癌组织中E-cadherin蛋白阳性表达是食管鳞癌男性患者术后预后的危险因素。
Aim: To investigate the effects of E-cadherin protein expression on survival of the patients with esophageal squamous cell carcinoma( ESCC). Methods: The biological samples and clinicopathological information of 5 620 patients with ESCC collected during 1985-2016 were derived from the clinical information database of 500 000 cases of esophageal and gastric cardia carcinoma of Henan key laboratory of esophageal cancer research. The expression of E-cadherin in ESCC tissue was determined by tissue microarray technology and SP immunohistochemical staining method. Results: The expression of E-cadherin was more in the female patients with lymph node metastasis and high pathological staging( P < 0. 05),which was higher in the male patients with low differentiation degree,lymph node metastasis and high pathological staging( P < 0. 05). The results of Cox regression showed that E-cadherin positive expression was the independent influencing factors of prognosis for the male patients( HR was 1. 126,95% CI was 1. 066-1. 189);but not for the female patients( P =0. 089). Conclusion: E-cadherin positive expression may be a risk factor for the prognosis of the male ESCC patients.
作者
韩少华
万里新
李秀敏
王海玲
董金城
靳艳
杨洋
肖凡凱
宋昕
胡守佳
赵学科
王建坡
王立东
HAN Shaohua;WAN Lixin;LI Xiumin;WANG Hailing;DONG Jincheng;JIN Yan;YANG Yang;XIAO Fankai;SONG Xin;HU Shoujia;ZHAO Xueke;WANG Jianpo;WANG Lidong(Henan Key Laboratory of Esophageal Cancer Research,the First Affiliated Hospital,Zhengzhou University,State Key Laboratory of Esophageal Cancer Prevention and Treatment,Zhengzhou 450052;Department of Oncology,Nanyang City Center Hospital,Nanyang,Henan 473003;Department of Gastroenterology,the Third Affiliated Hospital,Xinxiang Medical University,Xinxiang,Henan 453003;Department of Internal Medicine,Qixian People's Hospital,Qixian,Henan 456750;Department of Histology and Embryology,Basic Medical College,Xinxiang Medical University,Xinxiang,Henan 453003;Department of Pathology and Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001;Office of Cancer Prevention and Control,Anyang Tumor Hospital,Anyang,Henan 455000)
出处
《郑州大学学报(医学版)》
CAS
北大核心
2019年第2期182-186,共5页
Journal of Zhengzhou University(Medical Sciences)
基金
国家自然科学基金项目(U1804262
81872032)
河南省科技重大专项(161100311300)
河南省自然科学基金项目(162300410238)
关键词
食管鳞癌
E-CADHERIN
术后预后
esophageal squamous cell carcinoma
E-cadherin
postoperation prognosis